Saypha Filler Lidocaine

Saypha Filler Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, developed to correct moderate to severe nasolabial folds and for lip augmentation. It is suitable for practitioners and must be placed in the mid to deep dermis or submucosa. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate-buffered at pH 6.7 to 7.3, giving 2.3% sodium hyaluronate (equivalent to 23 mg/mL) with lidocaine HCl 0.3%, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

• Corrects moderate to severe nasolabial folds and augments the lips
• Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
• Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
• Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
• BDDE cross-linking agent present at 2 ppm or less
• Steam sterilised in the syringe, which serves as the sterile barrier
• Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
• Manufactured by Croma-Pharma in Austria

適応と専門的な使用

主な適応

• Moderate to severe nasolabial folds
• Lip augmentation

専門的な使用

Saypha Filler Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.

施術部位

• Nasolabial folds, by mid to deep dermis injection
• Lips, by submucosal injection

対象となる患者

For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

作用の仕組み： Saypha Filler Lidocaine ​

Allparaで注文する理由

Allparaは、正規品で検証済みの SAYPHA 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問